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ABSTRACT 
CONTEXT AND OBJECTIVE: Healthcare investments should consider short and long-term demands. The objectives here were to compare the average 
tenures of ministers of health in Brazil and in another 22 countries and to evaluate the relationship between ministers’ tenures and a number of 
indicators. 
DESIGN AND SETTING: Descriptive study conducted at Centro Paulista de Economia da Saúde (CPES).
METHODS: Twenty-two countries with the highest Human Development Indices (HDIs) and Brazil were included. The number of ministers over the 
past 20 years was investigated through each country’s Ministry of Health website. Pearson’s correlation coefficient was used to compare the number 
of ministers in each country with that country’s indicators. The Mann-Whitney test was used to compare ministers’ tenures in Brazil and other 
countries. 
RESULTS: The mean tenure (standard deviation, SD) of Brazilian ministers of health was 15 (12) months, a period that is statistically significantly 
shorter than the mean tenure of 33 (18) months in the other 22 countries (P < 0.05). There was a moderate and statistically significant positive 
correlation between the number of ministers and mortality rates for several conditions. The number of ministers also presented moderate and 
statistically significant negative correlations with per capita total healthcare expenditure (r = -0.567) and with per capita government healthcare 
expenditure (r = -0.530).
CONCLUSION: On average, ministers of health have extremely short tenures. There is an urgent need to think and plan healthcare systems from a 
long-term perspective. 
RESUMO
CONTEXTO E OBJETIVO: Investimentos em saúde deveriam considerar as demandas de curto e longo prazo. Os objetivos foram comparar o tempo 
médio no cargo dos ministros da saúde no Brasil e em outros 22 países e avaliar a relação entre o tempo médio dos ministros no cargo e alguns 
indicadores.
TIPO DE ESTUDO E LOCAL: Estudo descritivo realizado no Centro Paulista de Economia da Saúde (CPES).
MÉTODOS: Vinte e dois países com os Índices de Desenvolvimento Humano (IDHs) mais altos e o Brasil foram incluídos. O número de ministros da 
saúde nos últimos 20 anos foi pesquisado na página eletrônica do Ministério da Saúde de cada país. Coeficiente de correlação de Pearson (CCP) foi 
utilizado para comparar o número de ministros em cada país com os indicadores daquele país. O teste de Mann-Whitney foi usado para comparar 
o tempo de permanência do ministro da saúde no Brasil com os outros países.
RESULTADOS: O tempo médio (desvio padrão, DP) no cargo dos ministros brasileiros foi de 15 (12) meses, um período estatisticamente significante 
menor do que a média observada nos outros 22 países, 33 (18) meses (P < 0,05). Foi observada uma moderada e também estatisticamente 
significante correlação positiva entre o número de ministros e taxas de mortalidade para várias condições. Houve uma moderada e significante 
correlação negativa entre o número de ministros e o investimento em saúde per capita total (r = -0.567) e o investimento em saúde público per 
capita (r = -0.530).
CONCLUSÃO: O ministro da saúde permanece, na média, pouco tempo no cargo. Há uma premente necessidade de se pensar e planejar o sistema 
de saúde para o longo prazo.
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INTRODUCTION
Ideally, healthcare investment decisions should consider both 
short and long-term demands. As nations become more developed, 
with well structured healthcare systems, qualified resources and an ed-
ucated population, it becomes harder to justify healthcare policy de-
cisions that focus only on the short term. In less developed nations, 
the demand to alleviate the suffering of its already diseased population 
poses a tremendous challenge to its leaders in charge of healthcare pol-
icy and decision-making. Although preventive measures are obviously 
recognized and preferable to treatment measures, it is not possible to 
close our eyes to current demand and look only at the future. 
Healthcare systems in many developing nations face a major chal-
lenge: how to meet 21st century healthcare standards and the tech-
nology it demands with funds that, as a percentage of gross domestic 
product (GDP), are less than what developed nations were investing 
in healthcare in the 1980s. Furthermore, how can developing nations 
meet such expectations when they are still struggling with healthcare 
problems that rich countries overcame 40 or 50 years ago?1 This sce-
nario stresses the importance of having long-term goals, while at the 
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same time addressing short and medium-term needs, and recognizing 
the intrinsic limitations of the system itself. 
It is entirely possible to use the concepts and methods of evidence-
based medicine to demonstrate the effectiveness and quality of certain 
products and services. However, decisions on whether or not to pro-
vide them to the population require an accurate assessment of people’s 
healthcare needs and expectations, as well as a system of priorities and 
an objective understanding of the structural limitations of the health-
care system itself. In other words, although there are very good products 
and services available, it may not be possible to deliver them to all devel-
oping nations in any general manner. The art of making well grounded 
and justified decisions should therefore avoid the type of decisions that 
would place a Ferrari (a high-quality product) off-road (a system lack-
ing in infrastructure).2 Most, if not all healthcare policies in developing 
nations should bear this in mind.
Politics is a means of distributing power and strategy is a means of 
implementing policy.3 National policies typically reflect the composi-
tion of both the executive and the legislature.4
The Minister of Health, or a similarly named position in some 
countries, is usually the chief executive officer (CEO) of the healthcare 
system. Although there is significant variation between countries, the 
Ministry of Health is supposed to provide overall strategic direction and 
leadership for the healthcare system as well as helping to develop legisla-
tion, regulations and policies to support the strategic directions. Nowa-
days, it is equally important to face the challenge of and need for inno-
vation within the healthcare system, with the aim of moving it towards 
a new model that provides good value for money and, at the same time, 
improves both the quality of the healthcare provided and makes it more 
accessible to the population that it is supposed to serve.
Across all levels, and throughout the world, healthcare is becoming 
more complex.5 In this complex environment, which is constantly and 
quickly changing, leadership means managing with an awareness of the 
nuances, constraints and limitations imposed.6 Management generally 
involves five tasks: managing self, managing systems or organizations, 
managing context, managing relationships and managing change.7
Good leadership and management are therefore all about providing 
direction and securing the commitment of partners and staff, facilitat-
ing change and delivering better healthcare services through the effi-
cient, creative and responsible deployment of people and other resourc-
es.8 While leaders set the strategic vision and mobilize efforts towards its 
realization, good managers ensure effective organization and utilization 
of resources to achieve results and meet the aims.9
At present, lack of leadership and management capability is a con-
straint, especially at the operational levels of both the private and pub-
lic health sectors.9
More than 25 years ago, Eitzen and Yetman10 reported research find-
ings of great potential significance to theories of executive leadership. They 
found a curvilinear pattern between coach tenure and team performance in 
college basketball teams in the United States.  The longer the coach’s tenure 
was, the greater the team’s success was. However, after a certain length of 
time (13 years on average), team performance declined steadily.11
More recently, strategic management scholars have emphasized the 
role of executive leadership in strategy formation and organization and 
system performance.12
In such a complex environment, it can be hypothesized that if the 
main leader, or the chief executive under any name, changes on a short-
time basis, it is very hard to build a system that considers or is prepared 
for the medium and long terms, even if such public policies have been 
defined. In addition, it is a well known fact that the return on health-
care investments is normally seen only over the medium to long term, 
although returns are often difficult to measure, regardless of the time 
horizon.
OBJECTIVES
The objective of this study was to describe and compare the average 
tenures of ministers of health in Brazil with those in countries with the 
highest Human Development Indices (HDI)13 over the course of the 
past 20 years. This study also looked at the relationship between minis-
ters’ tenures and a number of demographic, socioeconomic and health-
care and health indicators.
MATERIAL AND METHODS 
Study design
This was a cross-sectional and exploratory study in which forty 
countries with the highest HDIs were initially selected, but only 23 
were included. We searched the Ministry of Health websites for each 
country, listing the number of ministers and the length of their tenure 
over the past 20 years. When this information was not available on the 
website, a standard e-mail was sent to the contact address on the web-
site. The e-mail message included a letter describing the purpose of the 
study and asked for the desired information, i.e. the number of minis-
ters of health over the past 20 years and how long each one remained in 
office.  If no response was received within two weeks, a second message 
was sent to the same e-mail address as well as to any alternate e-mail ad-
dresses identified at the Ministry of Health website. This procedure was 
repeated once more if no response was received within a further period 
of two weeks. All replies received within 45 days of the initial e-mail 
were considered for the study.
The number of Brazilian ministers of health and their tenures is 
available from the Brazilian Ministry of Health website.14
To gather the most recent socioeconomic, educational and health-
care indicators for the countries included in the study, we searched the 
World Health Organization (WHO)15 and World Bank16 websites. De-
scriptive statistics were used to characterize the data from each coun-
try. Pearson’s correlation coefficient was used to correlate the number of 
ministers in each country over the past 20 years with that country’s so-
cioeconomic, educational and healthcare indicators. The Mann-Whit-
ney test was used to compare ministers’ tenures in Brazil and other 
countries. 
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RESULTS 
The Ministry of Health website of each country was surveyed and 
provided the required data for only eight countries (20%). Among the 
remaining 33 countries to whose ministries of health we sent an e-mail 
asking for data and describing the study purpose, 20 (61%) replied 
within 45 days. Fifteen countries (45%) answered with the required 
data and  five countries (15%) stated that the data was not readily avail-
able or that they were unable or unwilling to provide it. Therefore, the 
required information was available for 22 of the 40 highest HDI coun-
tries (55%), plus Brazil, which is 70th in the HDI ranking; all of these 
were included in our analysis.
Table 1 lists the countries included in this study, along with their 
HDI rank, the number of ministers of health over the past 20 years, and 
the mean number of months (with standard deviation, SD) for the min-
isters’ tenure of each country. Switzerland, the 7th ranked country on 
the HDI list, had the smallest number of ministers of health (three over 
the past 20 years). The Netherlands, the United States and Singapore, 
ranked 9th, 12th and 25th, respectively, had a total of five ministers of 
health each over the course of the past 20 years. Among the top 40 HDI 
countries, Poland (ranked 37th) had 18 ministers of health over the past 
20 years, the largest number in the study. Brazil had 17 ministers over 
the past 20 years. The mean (SD) tenure of Brazilian ministers of health 
is 15 (12) months, a period that is statistically significantly shorter than 
Table 1. Median (with minimum-maximum, min-max), mean (with standard deviation, SD), number of months and number of ministers of health for each 
of the countries, in the last 20 years, ranked according to the Human Development Index (HDI), International Monetary Fund (IMF) and World Bank (WB) 
classifications of countries
HDI position Country
Number of months
median (min-max)
Number of  
months mean (SD)
Number of  
ministers
1 Iceland 26 (10-72) 34 (25) 8
2 Norway 36 (12-36) 27 (11) 8
3 Australia 36 (12- 85) 42 (27) 8
4 Canada 24.5 (4-55) 26 (17) 11
5 Ireland 26 (1-58) 27 (22) 9
6 Sweden 23 (1-70) 25 (21) 11
7 Switzerland 96 (84-108) 96 (17) 3
9 Netherlands 26 (3-102) 39 (46) 5
11 Finland 30.5 (12-48) 30 (14) 9
12 United States of America 47.5 (37- 96) 57 (26) 5
14 Denmark 21 (10-72) 26 (19) 10
15 Austria 31 (9-46) 30 (12) 9
16 United Kingdom 26.5 (17-44) 28 (9) 9
19 New Zealand 24 (8-71) 27 (19) 10
25 Singapore 42 (24-84) 48 (26) 5
26 South Korea 9 (0-21) 10 (5) 26
27 Slovenia 33 (6-61) 32 (20) 8
29 Portugal 35 (9-54) 34 (16) 9
32 Czech Republic 13 (1-29) 14 (10) 15
36 Hungary 18 (9-50) 20 (11) 13
37 Poland 13 (1-47) 13 (11) 18
40 Chile 32 (14-43) 30 (11) 10
Total (22 countries) 21 (0-108) 33 (18) 10 (5)
70 Brazil 13 (0- 47) 15 (12) 17
Total (23 countries) 20 (0-108) 32 (18) 10 (5)
IMF (Advanced economies: 18 countries) 23 (0-108) 28.6 (21.6) 9.05 (4.77)
IMF (Emerging and developing economies: 5 countries) 16 (0-50) 17.2 (12.1) 14.6 (3.21)
WB (High-income economies: 20 countries) 22 (0-108) 26.9 (20.7) 9.55 (4.77)
WB (Upper-middle-income economies: 3 countries) 15.5 (0-47) 17.1 (13) 15 (4.36)
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PCC
r P
HDI position - 2007/2008 (n = 23) 0.522 0.011
HDI value - 2007/2008 (n = 23) -0.517 0.011
Gross Domestic Product (GDP) (millions of US$) - 2007 (n = 23) -0.188 0.390
GDP per capita (PPP US$) - 2005 (n = 23) -0.598 0.003
Gross National Income (GNI) per capita (international PPP, US$) - 2006 (n = 23) -0.632 0.001
Gini Index - 2007/2008 (n = 22) 0.024 0.916
Population, total (millions) - 2005 (n = 23) 0.065 0.769
Population annual growth rate (%) - 2006 (n = 23) -0.230 0.290
Population in urban areas (%) - 2006 (n = 23) -0.102 0.643
Population median age (years) - 2006 (n = 23) -0.309 0.151
Population proportion over 60 (%) - 2006 (n = 23) -0.313 0.146
Population with sustainable access to improved drinking water sources (%) (n = 19) -0.693 0.001
Population with sustainable access to improved sanitation (%) - 2006 (n = 15) -0.578 0.024
Adult literacy rate (%) - 2000/2004 (n = 5) -0.572 0.313
Total fertility rate (per woman) - 2006 (n = 23) -0.264 0.224
Registration coverage of deaths (%) (n = 23) -0.455 0.029
Table 2. Pearson correlation coefficients (PCC) between the mean number of ministers of health and each country’s demographic and socioeconomic 
indicators (Brazil included)
HDI = Human Development Index; GDP = gross domestic product; PPP = purchasing power parity; US$ = United States dollars.
the mean tenure of 33 (18) months in the 22 other countries included 
in the study (P < 0.05). 
When the 23 countries were split into advanced economies (18 
countries) and emerging and developing economies (five countries) us-
ing International Monetary Fund (IMF) criteria,17 the mean (SD) num-
ber of ministers of health in each group was 9 (5) and 15 (3), respec-
tively. 
Table 2 presents Pearson’s correlation coefficient between the num-
ber of ministers of health over the past 20 years and a number of de-
mographic and socioeconomic indicators. There was a statistically sig-
nificant moderate positive correlation between the number of ministers 
over the period and a country’s HDI rank. There were statistically sig-
nificant moderate negative correlations between the number of minis-
ters and the HDI index, per capita gross domestic product (GDP) (in-
ternational purchasing power parity, PPP; United States dollars, US$), 
per capita gross national product (GNP) (international PPP; US$), per-
centage of the population with sustainable access to improved drinking 
water sources, percentage of the population with sustainable access to 
improved sanitation and registration coverage of deaths (%).
Table 3 shows Pearson’s correlation coefficient between the num-
ber of ministers of health over the past 20 years and healthcare cover-
age, healthcare system resources, mortality and the burden of illness, 
and risk factor indicators for each country. There were statistically sig-
nificant moderate negative correlations between the number of minis-
ters and general government expenditure on health as a percentage of 
total government expenditure, per capita total expenditure on health at 
the average exchange rate (US$), per capita total expenditure on health 
(international PPP, US$), per capita government expenditure on health 
(international PPP, US$), nursing and midwifery personnel density, 
physician density (numbers per 10,000 population) and healthy life ex-
pectancy (HALE) at birth (years) for both genders. There were also sta-
tistically significant moderate positive correlations between the num-
ber of ministers and the age-standardized mortality rate for cancer (per 
100,000 population), age-standardized mortality rate for cardiovascular 
diseases (per 100,000 population), age-standardized mortality rate for 
injuries (per 100,000 population), age-standardized mortality rate for 
non-communicable diseases (per 100,000 population), neonatal mor-
tality rate (per 1,000 live births), and prevalence of tuberculosis (per 
100,000 population).
DISCUSSION
In this study, it was observed that in the countries with the highest 
HDI, the average minister of health tenure was 33 months. Interesting-
ly, the average minister of health tenure over the past 20 years, in coun-
tries classified as advanced economies by the IMF, was almost twice as 
long (35 years) as for their counterparts in countries classified as emerg-
ing and developing economies (18 months). 
Brazil, currently ranked 70th according to the HDI, is a federation 
of 26 states and one Federal District. Over 5,500 municipalities enjoy 
federative status and political, administrative and financial autonomy. It 
has a national public health system, the so-called Unified Health Sys-
tem (Sistema Único de Saúde, SUS), which was formally created by the 
1988 Federal Constitution. Nominally, the publicly funded SUS should 
provide full coverage to the entire Brazilian population, offering a com-
plete range of services free of charge. It is the only service for over three-
Ministers of Health: short-term tenure for long-term goals?
Sao Paulo Med J. 2011;129(2):77-84 81
PCC
R P
Health service coverage
Women who have had mammography (%) - 2002/2004 (n = 17) -0.059 0.821
Women who have had Pap smear (%) - 2002/2004 (n = 16) 0.374 0.154
Health system resources
General government expenditure on health as percentage of total expenditure on health - 2006 (n = 23) -0.048 0.827
General government expenditure on health as percentage of total government expenditure - 2006 (n = 23) -0.455 0.029
Per capita total expenditure on health at average exchange rate (US$) - 2006 (n = 23) -0.581 0.004
Per capita government expenditure on health at average exchange rate (US$) - 2006 (n = 23) -0.514 0.012
Per capita total expenditure on health (international PPP, US$) - 2006 (n = 23) -0.567 0.005
Per capita government expenditure on health (international PPP, US$) - 2006 (n = 23) -0.530 0.009
Private expenditure on health as percentage of total expenditure on health - 2006 (n = 23) 0.048 0.827
Out-of-pocket expenditure as percentage of private expenditure on health - 2006 (n = 23) 0.266 0.220
Total expenditure on health as percentage of gross domestic product - 2006 (n = 23) -0.404 0.056
Hospital beds (per 10,000 population) (n = 22) 0.360 0.100
Number of nursing and midwifery personnel (n = 22) -0.153 0.485
Number of physicians (n = 23) -0.087 0.693
Nursing and midwifery personnel density (per 10,000 population) (n = 23) -0.458 0.028
Ratio of nurses and midwives to physicians (n = 23) -0.296 0.170
Physician density (per 10,000 population) (n = 23) -0.419 0.047
Mortality and burden of disease
Age-standardized mortality rate for cancer (per 100,000 population) - 2002 (n = 23) 0.542 0.008
Age-standardized mortality rate for cardiovascular diseases (per 100,000 population) - 2002 (n = 23) 0.508 0.013
Age-standardized mortality rate for injuries (per 100,000 population) - 2002 0.655 0.001
Age-standardized mortality rate for non-communicable diseases (per 100,000 population) - 2002 0.630 0.001
Neonatal mortality rate (per 1,000 live births) - 2004 (n = 23) 0.432 0.040
Infant mortality rate (IMR) - 2007 (n = 23) 0.324 0.132
Maternal mortality ratio (maternal deaths per 100,000 live births) - 2005 (n = 23) 0.323 0.133
Deaths among children under five years of age due to diarrheal diseases (%) - 2000 (n = 23) 0.302 0.162
Under-five mortality rate (probability of dying by age five years per 1000 live births) for both sexes - 2006 (n = 23) 0.319 0.138
Healthy life expectancy (HALE) at birth (years) for both sexes - 2003 (n = 23) -0.560 0.005
Life expectancy at birth (years) for both sexes - 2006 (n = 23) -0.506 0.014
Prevalence of tuberculosis (per 100,000 population) - 2006 (n = 23) 0.798 0.000
US$ = United States dollars, PPP = purchasing power parity.
Table 3. Pearson correlation coefficients (PCC) between the mean number of ministers of health and each country’s health service coverage, health system 
resources, mortality and burden of illness indicators (Brazil included) 
quarters of the population and the main provider for the poor. In fact, 
it is fraught with problems, mostly due to financing, management and 
structural causes, as well as governance failures, especially a lack of in-
centives and accountability that could be used to stimulate or enhance 
performance. The shortcomings of the national health service impact 
both healthcare management and delivery.18  
The Brazilian Ministry of Health was created in 1953. Since that 
time, 41 ministers have been appointed. For the past 56 years the average 
tenure of Brazilian ministers of health has been 16 months. Only three 
ministers remained in office for longer than three years. Over the past 
20 years, the average minister of health tenure in Brazil was statistically 
significantly lower than the average tenures observed in the 22 countries 
with the highest HDI that were included in this study (15 versus 33 
months; P = 0.015).
It is interesting to note that the average tenure for soccer coach-
es among the 20 best teams in Brazil over this same 20 years period 
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was around seven months.19,20 Thus, the average tenure for ministers of 
health in Brazil is twice that of soccer team coaches, but only half the 
tenure of their counterparts in countries with higher HDIs. 
Brazil is currently a politically stable democracy. However, as in most 
developing nations, there is an element of political instability. Some par-
ties are strong, yet not necessarily faithful to a given ideology. Senators, 
congressmen and elected and appointed executives have their own coali-
tions and interests. It is also fair to say that the ideological foundations 
of some parties or politicians are not rock solid, and decisions are often 
not made along party lines. The coalitions and power-sharing determine 
the best political arrangements for the time being. Political instability 
leads to uncertainty regarding the future of institutions and policymak-
ers, which in turn affects the behavior of public and private agents.21 
As Gordon and Rosen22 pointed out, newly appointed leaders do not 
function totally independently of their sponsors or of how those around 
them expect them to function.11 Political interests, personal agendas and 
different views of the world play an important role in defining the best 
arrangements for sharing and maintaining political power. 
Changing an organization takes time; continuity of leadership to 
build a consistent internal system to drive desired behaviors and actions 
is crucial. Ministers of health are not always allowed to remain in office, 
in spite of satisfactory performance.
Some authors have described the tenure of CEOs as life cycles in 
which the executive has a steep learning curve when he or she first takes 
office, but then grows stale as he/she loses touch with the outside envi-
ronment. Over recent years, a significant body of research has focused 
on the ways that top executives influence strategic choices and organiza-
tional performance.23 Interestingly, researchers have also found that or-
ganizations become reflections of their top executives.23-25 
A few studies have examined how the impact of CEOs varies over 
their time in office. Hambrick and Fukutomi11 proposed that new 
CEOs begin with a knowledge deficit, but steadily learn about their 
jobs, organizations and environments. After some time, however, CEOs 
are thought to become insular and overly wedded to their early for-
mulas, thereby resulting in an inverted U-shaped relationship between 
tenure and company performance. In line with this model, Miller and 
Shamsie,26 in a longitudinal study on the film industry, found that com-
pany performance increased for the first 8-10 years of a CEO’s tenure 
and then began to fall.23
In 2002, Lucier et al.27 studied the CEOs of the world’s 2,500 larg-
est publicly traded companies who left office during 2001. The study 
included 231 CEOs. Their average tenure when they left in 2001 had 
been 7.3 years. The average tenure of CEOs in the healthcare indus-
try was 9.1 years for CEOs who left office in 1995, 1998, 2000 and 
2001. The average age at which executives became healthcare indus-
try CEOs was 50.3 years for those leaving office  in 1995, 1998, 2000 
and 2001.27
More recently, Lucier et al.28 took a second look at the tenures of the 
CEOs of the world’s 2,500 largest public companies, selected based on 
their market cap on January 1, 2006. Globally, the average CEO ten-
ure had increased to 7.8 years, slightly higher than the average across 
the previous years studied. This average tenure was thought to provide 
enough time to implement an initial strategy, but also to allow for time-
ly removal of poorly performing CEOs and those engaged in illegal and 
unethical behavior.28
Although these long average tenures pertain to a completely differ-
ent environment, they allow us to think about and compare what hap-
pens in the healthcare system and private sector. In the UK, Taylor-Rob-
inson et al.29 published a qualitative study that explored issues relating 
to the time horizons used in healthcare decision-making processes. This 
study showed that many public healthcare decision makers and policy 
makers felt that the timescales for decision-making were too short. Sub-
stantial systemic barriers to longer-term planning existed. Furthermore, 
it was felt that longer term planning was needed to address the wider 
determinants of health and to achieve changes at societal level. Three 
prominent ‘system’ issues were identified as important drivers of short-
term thinking: the need to demonstrate an impact within the four-year 
political cycle; the requirement to ‘balance the books’ within the annual 
commissioning cycle; and the disruption caused by frequent reorganiza-
tions within the health service.29 
As pointed out by one participant in the UK study, politicians prob-
ably have a shorter viewpoint because they are thinking about the next 
election. Also, many participants felt that the frequent reorganizations 
within the health service itself were particularly disruptive in terms of 
long-term planning. It was even stated there was no long-term perspec-
tive think tank.29
The present study also evaluated the relationship between the num-
ber of ministers of health over the past 20 years and some demographic, 
socioeconomic and health system and health indicators. Interestingly, 
we found a number of expected correlations, even considering that we 
were analyzing quite a homogeneous group of countries: with the excep-
tion of Brazil, the countries studied were those with the highest HDI 
and were mostly (18 of 23) classified as advanced economies by the IMF. 
In general, there was a statistically significant, moderate and inverse cor-
relation between per capita or government expenditure and the num-
ber of ministers of health within the 20 year-period. The greater the per 
capita expenditure was, the lower the number of ministers was. It is also 
interesting to note that there was a relationship between the number of 
ministers and the mortality and burden of disease indicators. The high-
er the mortality rate for several conditions was, the lower the number 
of ministers within the last 20 year-period was (most of the correlations 
were moderate and statistically significant). 
This study has some limitations, since it merely uses average ten-
ures within a certain period of time and correlates them with the coun-
try’s demographic, socioeconomic, healthcare system and health indi-
cators. Although tempting, it is not possible to establish any causal re-
lationship. We can certainly develop hypotheses to address the issue of 
whether or not managerial tenure “causes” organizational and systemic 
outcomes, but further studies are required to document and assess the 
rationale behind such a hypothesis. 
It is important to emphasize that leadership and management are 
complex concepts that are relevant to many different parts of the health-
care system, including the private and public sectors, healthcare facil-
ities, district health offices and central ministries, as well as the sup-
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port systems relating to drugs, finance and information. Leadership and 
management are also human resource issues: specifically, the skills and 
motivation that managers and leaders need to work throughout a health 
system.9
Furthermore, individual political behavior and political outcomes 
in any society are constrained by its political institutions.30 Political in-
stitutions provide the structure for collective decision-making and de-
fine the context for resource redistribution and public good provision 
by governments.31 Long-term policymaking involves current decisions 
with distant consequences. Any choice that society makes today has 
consequences for other choices that public and private players and sub-
sequent societies can and will make in the future.32 
Care, in most countries, continues to be fragmented, unsafe and 
inefficient. As stated by Corrigan and McNeill, achieving high levels 
of performance requires organizational capacity, including information 
technology and specialized expertise that are not present in most set-
tings. Therefore, a comprehensive policy agenda is needed to encourage 
growth in organizational capabilities, including national priorities and 
goals, performance measurement and reporting, payment or compensa-
tion reform, community leadership, information technology and pub-
lic education.33  
In conclusion, the Minister of Health is a key decision-maker in 
healthcare systems and has the potential to highly influence policy-mak-
ing. The Minister of Health is usually responsible for providing over-
all direction and leadership for the system, focusing on planning and 
on guiding resources to bring value to the healthcare system. Constant 
change in an important office such as that of the Minister of Health is, 
in and of itself, a threat and a sign of poor sustainability and continu-
ity of the decision-making process and long-term healthcare policies. At 
the same time, it may be a consequence of a short-term view of the po-
litical environment, in which decision-making and policy-making are in 
a sense restricted to the elected mandate. It also has the potential, over 
the short term, to solve only the problems and satisfy only the needs 
and interests of specific groups, which may be another threat to the es-
tablishment of a system that should be committed to the community 
as a whole. 
While the challenges that developed and developing nations face 
are great, the opportunities for improvement of their healthcare sys-
tems are even greater. Significant resources are currently wasted, in part 
because of a lack of guided and justified decisions that take into con-
sideration not only the infrastructure in place, but also the adequacy of 
the time frame within which they are based. In spite of the short-term 
requirements, there is an urgent need to think and plan healthcare sys-
tems from a long-term perspective. A more efficient healthcare system 
focused on long-term policies and transparent and justified decisions 
must be the goal.
CONCLUSION 
On average, ministers of health have extremely short tenures. There 
is an urgent need to think and plan healthcare systems from a long-term 
perspective.
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